Rusoma Laboratories Pvt Ltd

Asthma management has long focused on controlling symptoms. A new discovery could shift that approach entirely.

Researchers have identified a specific immune molecule that plays a central role in triggering airway inflammation. Targeting it effectively could lead to therapies that prevent asthma episodes at their source, not just manage them after they begin.

Root-cause treatment is the future of medicine. Rusoma's approach to parenteral therapy reflects the same principle: address the need at its core.

The Sushruta Samhita, written over 2,500 years ago, remains one of the most remarkable medical texts in history.

It catalogued more than 120 surgical instruments, described techniques for rhinoplasty and cataract extraction, and laid down structured guidelines for surgical training and hospital management. These contributions predated similar developments in Europe by centuries.

Rusoma draws strength from this lineage. The precision and discipline that defined ancient Indian surgery continue to inform how we approach pharmaceutical manufacturing today.